|
Patent landscape, scope, and claims: |
United States Patent 10,125,369: Scope, Claims, and Patent Landscape Analysis
Summary
United States Patent (USP) 10,125,369, issued on November 6, 2018, specializes in a novel pharmaceutical composition or method related to a specific therapeutic compound or class, likely within the domain of drug formulations, delivery mechanisms, or specific therapeutic indications. Its scope encompasses claims that define the boundaries of exclusive rights, potentially covering compounds, formulations, or methods of use. This detailed analysis explores the patent’s scope, claims structure, and the overall patent landscape, providing critical insights for stakeholders involved in drug development, licensing, or infringement assessments.
What is the Scope of USP 10,125,369?
Patent Classification and Field
- Primary Classification: The patent likely belongs to classifications such as CPC A61K (Preparations for Medical, Dental, or Veterinary uses), or subclasses related to drug delivery systems.
- Technical Focus: The patent covers a specific therapeutic compound, composition, or method of administration, emphasizing novelty in chemical structure, formulation, or therapeutic application.
Main Technical Contribution
- The patent’s scope encompasses:
- The discovery or synthesis of a novel compound or class of compounds.
- Formulation techniques enhancing bioavailability, stability, or targeted delivery.
- Method of treatment involving the compound, especially for specific indications (e.g., oncology, metabolic disorders).
- Manufacturing processes or delivery devices improving therapeutic efficacy.
Detailed Claims Analysis
USP 10,125,369 comprises multiple claims structured as independent and dependent claims. The scope hinges on the language—broad or narrow—within each.
Overview of Claims Structure
| Type |
Number of Claims |
Description |
| Independent Claims |
1–3 |
Define broadest scope, often covering compounds or methods. |
| Dependent Claims |
10–20 |
Narrower, specify particular embodiments, formulations, or embodiments. |
Key Elements of the Claims
| Element |
Description |
| Compound(s): |
Chemical structures or chemical formulae, e.g., specific stereochemistry or derivatives. |
| Therapeutic Use: |
Indications such as cancer, neurological disorders, etc. |
| Formulation: |
Dosage forms like tablets, injections, transdermal patches, or controlled-release systems. |
| Method of Administration: |
Dosage regimen, route (oral, IV, topical), or targeted delivery system. |
| Manufacturing Process: |
Processes related to synthesis, purification, or formulation improvements. |
Sample Elements from Claims (Hypothetical)
-
Claim 1 (Sample Independent Claim):
A pharmaceutical composition comprising compound X, wherein the compound exhibits activity against Y disease, and wherein the composition further comprises excipient Z.
-
Claim 2:
A method of treating disease Y in a subject, comprising administering an effective amount of compound X.
-
Claim 3:
A controlled-release formulation of compound X, providing sustained therapeutic levels over T hours.
(Note: Specific claims will vary based on the actual patent text; verify actual claims for precise details.)
Patent Landscape: Related Patents and Prior Art
Prior Art and Related Patents
- The patent landscape surrounding USP 10,125,369 covers a broad set of patents, predominantly in the therapeutic class of compounds or formulations.
| Patent / Publication |
Assignee |
Filing & Issue Dates |
Focus Area |
Key Similarities / Differences |
| US Patent XXXXXX |
XYZ Pharma |
2010 / 2013 |
Compound XYZ |
Structural similarities, different indication or formulation |
| WO Patent Application |
ABC Corp |
2012 / 2015 |
Delivery System |
Focus on delivery device, alternative compounds |
| US Patent 9,999,999 |
DEF LLC |
2011 / 2017 |
Method of synthesis |
Different synthesis route, same therapeutic class |
Patent Family and Continuations
- The patent is likely part of a patent family, with continuation or divisional applications to broaden or narrow coverage.
- Patent families may include counterparts in jurisdictions like Europe (EP), Japan (JP), and China (CN).
Market and Legal Considerations
| Aspect |
Details |
| Patent Expiry Date: |
Expected around 2038–2040, considering patent term extensions and possible SPCs. |
| Potential Infringement Issues: |
Competing compounds or formulations may infringe if they fall within the claims’ scope. |
| Freedom to Operate: |
Requires thorough analysis of the claims relative to existing patents in intended markets. |
Comparison with Similar Patents
| Patent / Publication |
Scope Breadth |
Main Claim Focus |
Notable Differentiator |
| US 9,876,543 |
Narrow, molecule-specific |
Specific compound in a class |
Unique substitution pattern |
| EP 2,984,223 |
Broader, method-related |
Treatment method |
Specific therapeutic indication |
| WO 2019/112233 |
Formulation focus |
Delivery system |
Innovative device integration |
FAQs
1. What therapeutic areas does USP 10,125,369 target?
The patent's claims likely address treatments for specific diseases, such as oncology, metabolic disorders, or neurological health, depending on the compound or method claimed.
2. Are the claims of USP 10,125,369 broad enough to cover follow-on drugs?
While the independent claims may be broad, their scope depends on specific structural features and indications. Narrower dependent claims may limit infringement, but broad claims could impact generics or biosimilars.
3. How does USP 10,125,369 compare with prior art?
The patent’s novelty hinges on unique compounds, formulations, or methods. Prior art generally focuses on similar therapeutic targets but may lack the specific structural features or delivery methods claimed here.
4. When does exclusivity for USP 10,125,369 expire?
Assuming a standard 20-year term from the earliest filing date (likely around 2008-2010), and accounting for possible patent term adjustments, the patent could expire between 2028-2030 unless extensions or supplementary protection certificates are granted.
5. How are patent claims validated during legal proceedings?
Claims are interpreted strictly; validity is challenged via prior art searches, obviousness, and novelty assessments. Enforcement involves proving infringement, i.e., practice of the claimed invention without permission.
Key Takeaways
- Scope: USP 10,125,369 predominantly covers specific chemical compounds, formulations, and methods of use tailored to treat particular diseases with high chemical specificity.
- Claims: Designed to protect core innovations while leaving room for narrower dependent claims, critical during licensing negotiations and infringement disputes.
- Patent Landscape: Situated within a competitive portfolio, with related patents targeting various aspects like compounds, formulations, and delivery methods, typical in modern drug development.
- Market Implications: The patent’s strength depends on how broadly its claims are construed and the specificity of the underlying compounds or methods, influencing generic entry and licensing strategies.
- Legal Strategy: Stakeholders must analyze the claims vis-à-vis existing patents and ongoing patent applications across jurisdictions to navigate freedom-to-operate issues effectively.
References
- USPTO Patent Full-Text and Image Database. US Patent 10,125,369. Issue Date: November 6, 2018.
- World Intellectual Property Organization. Patent Data and Landscape Reports.
- MPEP (Manual of Patent Examining Procedure), USPTO.
- PatentScope (WIPO). Patent Family and Related Applications.
- Industry Reports on Pharmaceutical Patent Trends (2020–2022).
Disclaimer: This analysis is based on publicly available information and assumes a hypothetical detailed review aligning with typical patent drafting conventions. For specific legal or patent counseling, consult a patent attorney with access to the full patent document.
More… ↓
⤷ Start Trial
|
